维普中文期刊产品整合服务
26篇 您的检索式:作者名="Pierre Valla"
    题名 作者 年代 出处 被引量
1Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis显示文摘Ana-Carolina Cardoso Rami Moucari Claudio Figueiredo-Mendes Marie-Pierre Ripault Nathalie Giuily Corinne Castelnau Nathalie Boyer Tarik Asselah Michelle Martinot-Peignoux Sarah Maylin Roberto J. Carvalho-Filho Dominique Valla Pierre Bedossa Patrick Marcel 2010Journal of Hepatology2010,,5:3
2<ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick 2008Gastroenterology2008,,2:2
3High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study显示文摘Rami Moucari Anneke Korevaar Olivier Lada Michelle Martinot-Peignoux Nathalie Boyer Vincent Mackiewicz Agnes Dauvergne Ana C. Cardoso Tarik Asselah Marie-Hélène Nicolas-Chanoine Michel Vidaud Dominique Valla Pierre Bedossa Patrick Marcellin 2009Journal of Hepatology2009,,6:2
4Ischemic Cholangiopathy显示文摘Pierre Deltenre Dominique-Charles Valla 2008Semin Liver Dis2008,,03:1
5Impact of ribavirin dose on retreatment of chronic hepatitis C patients显示文摘AIM: To study the efficacy and factors associated with a sustained virological response (SVR) in chronic hepatitis C (CHC) relapsing patients. METHODS: Out of 1228 CHC patients treated with pegylated interferon (PEG-IFN) and ribavirin (RBV), 165 (13%) had a relapse. Among these, 62 patients were retreated with PEG-IFN-2a or-2b and RBV. Clinical, biological, virological and histological data were collected. Initial doses and treatment modifications were recorded. The efficacy of retreatment and predictive factors for SVR were analyzed. RESULTS: An SVR was achieved in 42% of patients. SVR was higher in young (< 50 years) (61%) than old patients (27%) (P = 0.007), and in genotype 2 or 3 (57%) than in genotype 1 or 4 (28%) patients (P = 0.023). Prolonging therapy for at least 24 wk more than the previous course was associated with higher SVR rates (53% vs 28%, P = 0.04). Also, a better SVR rate was observed with RBV dose/body weight > 15.2 mg/kg per day (70% vs 35%, P = 0.04). In logistic regression, predictors of a response were age (P = 0.018), genotype (P = 0.048) and initial RBV dose/body weight (P = 0.022). None of the patients without a complete early virological response achieved an SVR (negative predictive value = 100%). CONCLUSION: Retreatment with PEG-IFN/RBV is effective in genotype 2 or 3 relapsers, especially in young patients. A high dose of RBV seems to be important for the retreatment response.Christiane Stern Michelle Martinot-Peignoux Marie Pierre Ripault Nathalie Boyer Corinne Castelnau Dominique Valla Patrick Marcellin 2012World Journal of Gastroenterology2012,18,23:1
6<ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick 2008Gastroenterology2008,,2:1
7Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: Role of biopsy显示文摘Thomas Sersté Vincent Barrau Violaine Ozenne Marie‐Pierre Vullierme Pierre Bedossa Olivier Farges Dominique‐Charles Valla Valérie Vilgrain Valérie Paradis Fran?oise Degos 2012Hepatology2012,,3:1
8Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection显示文摘Ivan Bièche Tarik Asselah Ingrid Laurendeau Dominique Vidaud Claude Degot Valérie Paradis Pierre Bedossa Dominique-Charles Valla Patrick Marcellin Michel Vidaud 2004Virology2004,,1:1
9Abnormal Plasma Microparticles Impair Vasoconstrictor Responses in Patients With Cirrhosis显示文摘Pierre–Emmanuel Rautou Julie Bresson Yannis Sainte–Marie Anne–Clemence Vion Valerie Paradis Jean–Marie Renard Cecile Devue Christophe Heymes Philippe Letteron Laure Elkrief Didier Lebrec Dominique Valla Alain Tedgui Richard Moreau Chantal M. Boulanger 2012Gastroenterology2012,,1:1
10A review of the basic principles for proton magnetic resonance sounding measurements显示文摘Anatoly Legchenko Pierre Valla 2002Journal of Applied Geophysics2002,50,1:1
11Portal cavernoma-associated cholangiopathy: A clinical and MR cholangiography coupled with MR portography imaging study显示文摘Bertrand Condat Valérie Vilgrain Tarik Asselah Dermot O’Toole Pierre Rufat Magali Zappa Richard Moreau Dominique Valla 2003Hepatology2003,,:1
12 Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick 2008Gastroenterology2008,,2:1
13Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C显示文摘Tarik Asselah Ivan Bièche Ingrid Laurendeau Valérie Paradis Dominique Vidaud Claude Degott Michelle Martinot Pierre Bedossa Dominique Valla Michel Vidaud Patrick Marcellin 2005Gastroenterology2005,,6:1
14A Review of the Basic Principles for Proton Magnetic Resonance Sounding Measurements 显示文摘ANATOLY LEGCHENKO PIERRE VALLA 2002Journal of Applied Geophysics2002,50,12:1
151-D modeling for proton magnetic sounding measurements over an electrically conductive medium显示文摘Pierre Valla etc 2002Journal of Applied Geophysics2002,50,1:1
16Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: Results of a longitudinal study显示文摘Filipe Nery Sylvie Chevret Bertrand Condat Emmanuelle de Raucourt Larbi Boudaoud Pierre‐Emmanuel Rautou Aurelie Plessier Dominique Roulot Cendrine Chaffaut Valerie Bourcier Jean‐Claude Trinchet Dominique‐Charles Valla 2015Hepatology2015,,2:1
17Processing of Surface Proton Magnetic Resonance Signals Using Non-Linear Fitting 显示文摘ANATOLY LEGCHENKO PIERRE VALLA 1998Journal of Applied Geophysics1998,39,2:1
18Removal of Power-Line Harmonics from Proton Magnetic Resonance Measurements 显示文摘ANATOLY LEGCHENKO PIERRE VALLA 2003Journal of Applied Geophysics2003,53,23:1
19Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C显示文摘Laure Elkrief Pascale Chouinard Noelle Bendersky David Hajage Béatrice Larroque Gérard Babany Blaise Kutala Claire Francoz Nathalie Boyer Richard Moreau Fran?ois Durand Patrick Marcellin Pierre‐Emmanuel Rautou Dominique Valla 2014Hepatology2014,,3:1
20Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites显示文摘Thomas Sersté Christian Melot Claire Francoz Fran?ois Durand Pierre‐Emmanuel Rautou Dominique Valla Richard Moreau Didier Lebrec 2010Hepatology2010,,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费